Sudden cardiac death in young athletes: exome sequencing results

Abstract

BACKGROUND: Ranking risks and prevention of sudden cardiac death in professional young athletes is a crucial unresolved problem in sports medicine. Intense physical exertion can lead to adaptive changes in the cardiovascular system, which can mask inherited diseases with predominant myocardial involvement, such as hypertrophic cardiomyopathy. Undiagnosed cases of such diseases can be a risk factor for fatal outcomes associated with training and competitive activities, making this problem extremely relevant.

AIM: To conduct a diagnostic search for possible molecular causes of cardiovascular diseases associated with a high risk of sudden death in young athletes.

MATERIALS AND METHODS: Whole-exome sequencing of DNA extracted from two groups of biomaterials was performed: nine autopsy samples of heart tissues from young athletes who died during intense physical exertion and three venous blood samples from active athletes of the Russian national team. Obtained data were subjected to bioinformatic analysis and clinical interpretation.

RESULTS: In total, 12 DNA samples were analyzed using a panel of 277 genes associated with the development of cardiovascular diseases with a high risk of sudden death. In 4 of 12 samples (33.3%), variants possibly related to the phenotype were found upon clinical interpretation of the sequencing results. A pathogenic variant was found in the MYBPC3 gene, leading to the development of hypertrophic cardiomyopathy (OMIM: 115197), and a potential pathogenic variant was found in the TRPM4 gene, associated with progressive familial heart block type IB (OMIM: 618531). Moreover, two variants with uncertain clinical significance were found in CAV3 and SCN1B.

CONCLUSION: Currently, data from high-throughput sequencing are collected to identify the molecular basis of cardiovascular diseases with a high risk of sudden cardiac death. Identifying young athletes who are carriers of pathogenic and possibly pathogenic gene variants is beneficial for preventing fatal outcomes and personalizing medical support for professional athletes.

Keywords

sudden cardiac death / athletes / hereditary myocardial disease / autopsy-negative death / sequencing / exome / pathogenic variants

References

[1] Shlyakhto EV, Arutyunov GP, Belenkov YN, et al. National recommendations on risk assessment and prevention of sudden cardiac death (2nd edition). Moscow: “Medpraktika-M”; 2018. 247 p. (In Russ.). EDN: OGIVYR

[2] Шляхто Е.В., Арутюнов Г.П., Беленков Ю.Н., и др. Национальные Рекомендации по определению риска и профилактике внезапной сердечной смерти (2-е издание). Москва: ИД «МеДпрактИка-М», 2018. 247 с. EDN: OGIVYR

[3] Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Rev Esp Cardiol (Engl Ed). 2016;69(2):176. doi: 10.1016/j.rec.2016.01.001

[4] Priori S.G., Blomström-Lundqvist C., Mazzanti A., et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death // Rev Esp Cardiol (Engl Ed). 2016. Vol. 69, N 2. P. 176. doi: 10.1016/j.rec.2016.01.001

[5] Gavrilova EA. The athlete’s heart. Actual problems of sports cardiology. Moscow: Izdatel’stvo «Sport»; 2022. 432 p. (In Russ.). EDN: GZBJJQ

[6] Гаврилова Е.А. Сердце спортсмена. Актуальные проблемы спортивной кардиологии. Москва: Издательство «Спорт», 2022. С. 432 с. EDN: GZBJJQ

[7] Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol. 2011;57(11):1291–1296. doi: 10.1016/j.jacc.2010.10.037

[8] Steinvil A., Chundadze T., Zeltser D., et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? // J Am Coll Cardiol. 2011. Vol. 57, N 11. P. 1291–1296. doi: 10.1016/j.jacc.2010.10.037

[9] Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: a decade in review. Circulation. 2015;132(1):10–19. doi: 10.1161/CIRCULATIONAHA.115.015431

[10] Harmon K.G., Asif I.M., Maleszewski J.J., et al. Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: a decade in review // Circulation. 2015. Vol. 132, N 1. P. 10–19. doi: 10.1161/CIRCULATIONAHA.115.015431

[11] Malhotra A, Dhutia H, Yeo TJ, et al. Accuracy of the 2017 international recommendations for clinicians who interpret adolescent athletes’ ECGs: a cohort study of 11 168 British white and black soccer players. Br J Sports Med. 2020;54(12):739–745. doi: 10.1136/bjsports-2017-098528

[12] Malhotra A., Dhutia H., Yeo T.J., et al. Accuracy of the 2017 international recommendations for clinicians who interpret adolescent athletes’ ECGs: a cohort study of 11 168 British white and black soccer players // Br J Sports Med. 2020. Vol. 54, N 12. P. 739–745. doi: 10.1136/bjsports-2017-098528

[13] Kumar A, Avishay DM, Jones CR. et al. Sudden cardiac death: epidemiology, pathogenesis and management. Rev Cardiovasc Med. 2021;22(1):147–158. doi: 10.31083/j.rcm.2021.01.207

[14] Kumar A., Avishay D.M., Jones C.R., et al. Sudden cardiac death: epidemiology, pathogenesis and management // Rev Cardiovasc Med. 2021. Vol. 22, N 1. P. 147–158. doi: 10.31083/j.rcm.2021.01.207

[15] Smolenskiy AV, Mikhaylova AV. Cardiology. National leadership. Sports and cardiovascular diseases. Cardiology: News. Opinions. Learning. 2019;7(4):62–65. EDN: MHOIEP

[16] Смоленский А.В., Михайлова А.В. Кардиология: национальное руководство. Спорт и сердечно-сосудистые заболевания // Кардиология: Новости. Мнения. Обучение. 2019. Т. 7, № 4. С. 62–65. EDN: MHOIEP

[17] https://rosrid.ru/ [Internet]. Study protocol. Available from: https://rosrid.ru/nioktr/detail/R4RNNYCT62QS8A3RFZT8JITC

[18] https://rosrid.ru/ [интернет]. Протокол исследования. Режим доступа: https://rosrid.ru/nioktr/detail/R4RNNYCT62QS8A3RFZT8JITC

[19] Huang J, Liang X, Xuan Y, et al. A reference human genome dataset of the BGISEQ-500 sequencer. Gigascience. 2017;6(5):1–9. Corrected and republished from: Gigascience. 2018;7:12. doi: 10.1093/gigascience/gix024

[20] Huang J., Liang X., Xuan Y., et al. A reference human genome dataset of the BGISEQ-500 sequencer // Gigascience. 2017. Vol. 6, N 5. P. 1–9. Corrected and republished from: Gigascience. 2018. Vol. 7, N 12. doi: 10.1093/gigascience/gix024

[21] https://github.com/ [Internet]. Programme package. Available from: https://github.com/google/deepvariant

[22] https://github.com/ [интернет]. Программный пакет. Режим доступа: https://github.com/google/deepvariant

[23] https://github.com/ [Internet]. Programme package. Available from: https://github.com/a-xavier/tapes

[24] Программный пакет. Режим доступа: https://github.com/a-xavier/tapes

[25] Hallıoğlu KO, Giray D, Bişgin A, et al. Familial hypertrophic cardiomyopathy: a case with a new mutation in the MYBPC3 gene. Turk Kardiyol Dern Ars. 2017;45(5):450–453. doi: 10.5543/tkda.2016.56267

[26] Hallıoğlu K.O., Giray D., Bişgin A., et al. Familial hypertrophic cardiomyopathy: a case with a new mutation in the MYBPC3 gene // Turk Kardiyol Dern Ars. 2017. Vol. 45, N 5. P. 450–453. doi: 10.5543/tkda.2016.56267

[27] https://www.ncbi.nlm.nih.gov/ [Internet]. ClinVar. NM_001037.5(SCN1B):c.632G>A (p.Cys211Tyr) AND Brugada syndrome 5. Available from: https://www.ncbi.nlm.nih.gov/clinvar/RCV001080509/

[28] https://www.ncbi.nlm.nih.gov/ [Internet]. ClinVar. NM_001037.5(SCN1B):c.632G>A (p.Cys211Tyr) AND Brugada syndrome 5. Режим доступа: https://www.ncbi.nlm.nih.gov/clinvar/RCV001080509/

[29] https://www.ncbi.nlm.nih.gov/ [Internet]. ClinVar. NM_033337.3:c.233C>T. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/8293/

[30] https://www.ncbi.nlm.nih.gov/ [Internet]. ClinVar. NM_033337.3:c.233C>T. Режим доступа: https://www.ncbi.nlm.nih.gov/clinvar/variation/8293/

[31] Klass AL, Krylova NS, Lysenko AV, et al. The prevalence of mutations in the MYBPC3 gene in Russian patients with hypertrophic cardiomyopathy. Molekularnaa genetika mikrobiologia i virusologia. 2023;41(1):18–23. EDN: RKSIGT

[32] Класс А.Л., Крылова Н.С., Лысенко А.В., и др. Распространенность мутаций в гене MYBPC3 у русских пациентов с гипертрофической кардиомиопатией // Молекулярная генетика, микробиология и вирусология. 2023. T. 41, № 1. С. 18–23. EDN: RKSIGT

[33] Marian AJ. Molecular genetic basis of hypertrophic cardiomyopathy. Circ Res. 2021;128(10):1533–1553. doi: 10.1161/CIRCRESAHA.121.318346

[34] Marian A.J. Molecular genetic basis of hypertrophic cardiomyopathy // Circ Res. 2021. Vol. 128, N 10. P. 1533–1553. doi: 10.1161/CIRCRESAHA.121.318346

[35] https://www.omim.org/ [Internet]. Transient receptor potential cation channel, subfamily M, member 4; TRPM4. Available from: https://www.omim.org/entry/606936?search=TRPM4&highlight=trpm4

[36] https://www.omim.org/ [Internet]. Transient receptor potential cation channel, subfamily M, member 4; TRPM4. Режим доступа: https://www.omim.org/entry/606936?search=TRPM4&highlight=trpm4

[37] Subbotina E, Williams N, Sampson BA, et al. Functional characterization of TRPM4 variants identified in sudden unexpected natural death. Forensic Sci Int. 2018;293:37–46. doi: 10.1016/j.forsciint.2018.10.006

[38] Subbotina E., Williams N., Sampson B.A., et al. Functional characterization of TRPM4 variants identified in sudden unexpected natural death // Forensic Sci Int. 2018. Vol. 293. P. 37–46. doi: 10.1016/j.forsciint.2018.10.006

[39] https://www.genecards.org/ [Internet]. GeneCards Symbol: TRPM4 2 transient receptor potential cation channel subfamily M member 4. Available from: https://www.genecards.org/cgi-bin/carddisp.pl?gene=TRPM4

[40] https://www.genecards.org/ [Internet]. GeneCards Symbol: TRPM4 2 Transient Receptor Potential Cation Channel Subfamily M Member 4. Режим доступа: https://www.genecards.org/cgi-bin/carddisp.pl?gene=TRPM4

[41] Dong Y, Du R, Fan LL, et al. Whole-exome sequencing identifies a novel TRPM4 mutation in a Chinese family with atrioventricular block. Biomed Res Int. 2021;2021:9247541. doi: 10.1155/2021/9247541

[42] Dong Y., Du R., Fan L.L., et al. Whole-exome sequencing identifies a novel trpm4 mutation in a Chinese family with atrioventricular block // Biomed Res Int. 2021. Vol. 2021. P. 9247541. doi: 10.1155/2021/9247541

[43] Finocchiaro G, Papadakis M, Robertus JL, et al. Etiology of sudden death in sports: insights from a United Kingdom regional registry. J Am Coll Cardiol. 2016;67(18):2108–2115. doi: 10.1016/j.jacc.2016.02.062

[44] Finocchiaro G., Papadakis M., Robertus J.L., et al. Etiology of sudden death in sports: insights from a United Kingdom regional registry // J Am Coll Cardiol. 2016. Vol. 67, N 18. P. 2108–2115. doi: 10.1016/j.jacc.2016.02.062

[45] Gordeeva MV, Mitrofanova LB, Pakhomov AV, et al. Sudden cardiac death in adolescents and young adults. Journal of Arrhythmology. 2012;(68):34–44. EDN: RRQFLD

[46] Гордеева М.В., Митрофанова Л.Б., Пахомов А.В., и др. Внезапная сердечная смерть молодых людей // Вестник аритмологии. 2012. № 68. С. 34–44. EDN: RRQFLD

[47] Fellmann F, van El CG, Charron P, et al. European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. Eur J Hum Genet. 2019;27(12):1763–1773. doi: 10.1038/s41431-019-0445-y

[48] Fellmann F., van El C.G., Charron P., et al. European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death // Eur J Hum Genet. 2019. Vol. 27, N 12. P. 1763–1773. doi: 10.1038/s41431-019-0445-y

[49] Mitrofanova LB. Multidisciplinary approach to the problem of sudden cardiac death. Morphologist’s view. Clinical and Experimental Surgery. Petrovsky Journal. 2018:6(3):16–24. EDN: UZQAUI doi: 10.24411/2308-1198-2018-13002

[50] Митрофанова Л.Б. Мультидисциплинарный подход к проблеме внезапной сердечной смерти. Взгляд морфолога // Клиническая и экспериментальная хирургия. Журнал имени академика Б.В. Петровского. 2018. Т. 6, № 3. С. 16–24. EDN: UZQAUI doi: 10.24411/2308-1198-2018-13002

[51] Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8(8):1308–1339. doi: 10.1016/j.hrthm.2011.05.020

[52] Ackerman M.J., Priori S.G., Willems S., et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European heart rhythm association (EHRA) // Heart Rhythm. 2011. Vol. 8, N 8. P. 1308–1339. doi: 10.1016/j.hrthm.2011.05.020

[53] Han J, Lalario A, Merro E, et al. Sudden cardiac death in athletes: facts and fallacies. J Cardiovasc Dev Dis. 2023;10(2):68. doi: 10.3390/jcdd10020068

[54] Han J., Lalario A., Merro E., et al. Sudden cardiac death in athletes: facts and fallacies // J Cardiovasc Dev Dis. 2023. Vol. 10, N 2. P. 68. doi: 10.3390/jcdd10020068

[55] Boytsov SA, Kolos IP, Lidov PI, et al. National recommendations on admission of athletes with cardiovascular system abnormalities to the training and competition process. Rational Pharmacotherapy in Cardiology. 2011;7(6):1–59. (In Russ.). EDN: OPRUET

[56] Бойцов С.А., Колос И.П., Лидов П.И., и др. Национальные рекомендации по допуску спортсменов с отклонениями со стороны сердечно-сосудистой системы к тренировочно-соревновательному процессу // Рациональная фармакотерапия в кардиологии. 2011. Т. 7, № 6S. С. 1–59. EDN: OPRUET

[57] Sadeghi M, Golshahi J, Talaei M, et al. 15-Year lipid profile effects on cardiovascular events adjusted for cardiovascular risk factors: a cohort study from Middle-East. Acta Cardiol. 2021;76(2):194–199. doi: 10.1080/00015385.2020.1717096

[58] Sadeghi M., Golshahi J., Talaei M., et al. 15-Year lipid profile effects on cardiovascular events adjusted for cardiovascular risk factors: a cohort study from Middle-East // Acta Cardiol. 2021. Vol. 76, N 2. P. 194–199. doi: 10.1080/00015385.2020.1717096

[59] Asatryan B, Schaller A, Seiler J, et al. Usefulness of genetic testing in sudden cardiac arrest survivors with or without previous clinical evidence of heart disease. Am J Cardiol. 2019;123(12):2031–2038. doi: 10.1016/j.amjcard.2019.02.061

[60] Asatryan B., Schaller A., Seiler J., et al. Usefulness of genetic testing in sudden cardiac arrest survivors with or without previous clinical evidence of heart disease // Am J Cardiol. 2019. Vol. 123, N 12. P. 2031–2038. doi: 10.1016/j.amjcard.2019.02.061

[61] Ivanova AA, Ivanoshchuk DE, Orlov PS, et al. Sudden cardiac death in young men: results of exome sequencing. Ateroscleroz. 2022;18(4):317–337. EDN: EDYQLL doi: 10.52727/2078-256X-2022-18-4-317-337

[62] Иванова А.А., Иванощук Д.Е., Орлов П.С., и др. Внезапная сердечная смерть у молодых мужчин: результаты экзомного секвенирования // Атеросклероз. 2022. Т. 18, № 4. С. 317–337. EDN: EDYQLL doi: 10.52727/2078-256X-2022-18-4-317-337

RIGHTS & PERMISSIONS

Eco-Vector